back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-06 15:24 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+42,517 vol |
42,517 | |
| Filed 2023-03-06 15:24 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-06 15:23 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+21,258 vol |
125,702 | |
| Filed 2023-03-06 15:23 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+68,058 vol |
342,783 | |
| Filed 2022-07-27 17:48 Tx date 2022-07-25 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+35,000 vol |
104,444 | |
| Filed 2022-05-12 08:09 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
274,725 | ||
| Filed 2022-05-12 08:09 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
69,444 | ||
| Filed 2022-05-12 08:08 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-12 08:08 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-10 16:27 Tx date 2022-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-84,624.64
-3,889 vol $21.76 each |
72,708 | |
| Filed 2022-03-08 10:44 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-96,187.14
-4,074 vol $23.61 each |
76,597 | |
| Filed 2022-03-08 10:42 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$188,006
+7,963 vol $23.61 each |
80,671 | |
| Filed 2022-03-08 10:41 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,963 vol |
20,431 | |
| Filed 2022-03-04 17:17 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-258,869.49
-11,077 vol $23.37 each |
72,708 | |
| Filed 2022-03-03 18:13 Tx date 2022-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-150,971.16
-6,338 vol $23.82 each |
83,785 | |
| Filed 2022-03-03 18:12 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-41,784.60
-1,716 vol $24.35 each |
90,123 | |
| Filed 2022-03-03 18:10 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,551
+5,074 vol $24.35 each |
91,839 | |
| Filed 2022-03-03 18:09 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,060.70
-1,522 vol $24.35 each |
75,648 | |
| Filed 2022-03-03 18:08 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,623
+4,502 vol $24.35 each |
77,170 | |
| Filed 2022-03-03 18:01 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,074 vol |
28,394 | |
| Filed 2022-03-03 18:00 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,502 vol |
33,468 | |
| Filed 2022-03-03 17:58 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-151,773.55
-6,233 vol $24.35 each |
83,785 | |
| Filed 2022-03-03 17:57 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$422,472
+17,350 vol $24.35 each |
90,018 | |
| Filed 2022-03-03 17:56 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-17,350 vol |
16,073 | |
| Filed 2022-03-03 17:56 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+17,350 vol |
33,423 | |
| Filed 2021-03-11 18:26 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-410,839.17
-12,461 vol $32.97 each |
72,668 | |
| Filed 2021-03-11 18:24 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,546 vol |
85,129 | |
| Filed 2021-03-11 18:24 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+22,957 vol |
80,583 | |
| Filed 2021-03-11 18:23 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,546 vol |
37,970 | |
| Filed 2021-03-11 18:22 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-22,957 vol |
16,073 | |
| Filed 2021-03-05 19:09 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+16,476 vol |
39,030 | |
| Filed 2021-03-05 18:55 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+46,138 vol |
68,692 | |
| Filed 2021-03-05 18:55 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+46,138 vol |
||
| Filed 2021-03-05 18:54 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,749 vol |
245,353 | |
| Filed 2021-03-05 18:52 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+23,892 vol |
42,516 | |
| Filed 2021-03-03 20:31 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-104,094.46
-3,313 vol $31.42 each |
57,626 | |
| Filed 2021-03-03 20:30 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$300,877
+9,576 vol $31.42 each |
60,939 | |
| Filed 2021-03-03 20:29 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-300,877.92
-9,576 vol $31.42 each |
||
| Filed 2021-03-03 20:28 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-9,576 vol |
18,624 | |
| Filed 2020-03-12 10:24 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-46,929.44
-2,239 vol $20.96 each |
51,363 | |
| Filed 2020-03-12 10:24 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$95,284
+4,546 vol $20.96 each |
53,602 | |
| Filed 2020-03-12 10:23 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-95,284.16
-4,546 vol $20.96 each |
28,200 | |
| Filed 2020-03-11 17:13 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-61,075.56
-2,499 vol $24.44 each |
49,056 | |
| Filed 2020-03-11 17:12 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,984
+5,073 vol $24.44 each |
51,555 | |
| Filed 2020-03-11 17:11 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-123,984.12
-5,073 vol $24.44 each |
32,746 | |
| Filed 2020-03-11 16:47 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
22,554 | |
| Filed 2020-03-11 16:46 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,004 vol |
13,550 | |
| Filed 2020-03-11 16:46 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+56,858 vol |
212,604 | |
| Filed 2020-03-11 16:44 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,506 vol |
37,819 | |
| Filed 2020-02-28 17:12 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-309,193.26
-11,703 vol $26.42 each |
46,482 | |
| Filed 2020-02-28 17:11 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$744,462
+28,178 vol $26.42 each |
58,185 | |
| Filed 2020-02-28 17:10 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$138,703
+5,242 vol $26.46 each |
30,007 | |
| Filed 2020-02-28 17:09 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-5,461 vol |
4,546 | |
| Filed 2020-01-10 12:39 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-62,311.56
-2,118 vol $29.42 each |
24,765 | |
| Filed 2020-01-10 12:39 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$160,662
+5,461 vol $29.42 each |
26,883 | |
| Filed 2020-01-10 12:38 Tx date 2020-01-07 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-160,662.62
-5,461 vol $29.42 each |
24,313 | |
| Filed 2019-07-23 19:50 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-46,091.25
-2,169 vol $21.25 each |
17,105 | |
| Filed 2019-07-23 19:50 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$116,046
+5,461 vol $21.25 each |
19,274 | |
| Filed 2019-07-23 19:49 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,461 vol |
21,120 | |
| Filed 2019-05-10 18:06 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-16,292.43
-693 vol $23.51 each |
18,130 | |
| Filed 2019-05-10 18:05 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$47,513
+2,021 vol $23.51 each |
18,823 | |
| Filed 2019-05-10 18:05 Tx date 2019-05-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,021 vol |
35,235 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,103
+4,546 vol $23.56 each |
18,359 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,682.92
-1,557 vol $23.56 each |
16,802 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-107,103.76
-4,546 vol $23.56 each |
37,256 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+44,290 vol |
155,746 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+15,221 vol |
41,802 | |
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,813 | ||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
10,007 | ||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
26,581 | ||
| Filed 2018-08-20 Tx date 2018-08-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
111,456 |